Global Omics Lab Services Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

List of Tables

The global demand for Omics Lab Services Market is presumed to reach the market size of nearly USD 391.62 BN by 2030 from USD 66.38 BN in 2022 with a CAGR of 24.84% under the study period 2023-2030.

Omics lab services encompass a range of laboratory services that utilize high-throughput techniques to study biological systems at the molecular level. The term omics refers to a variety of fields, including genomics, transcriptomics, proteomics, and metabolomics. Genomics involves the study of an organism's entire genetic material (its genome) to identify genes and their functions. Transcriptomics is the study of an organism's complete set of RNA molecules (transcriptome), while proteomics is the study of an entire set of proteins (proteome) found in an organism. Metabolomics is the study of an organism's complete set of small molecule metabolites (metabolome). Omics lab services are used in a variety of fields, including drug discovery and development, personalized medicine, and agricultural research. These services can provide valuable insights into the underlying mechanisms of disease, identify potential drug targets, and help to improve the efficacy and safety of treatments. Some of the specific services offered by omics labs include DNA sequencing, RNA sequencing, protein identification and quantification, and metabolite profiling. Omics lab service providers use a variety of high-throughput techniques to generate large amounts of data, which can then be analyzed using bioinformatics tools to extract meaningful information.

Market Dynamics:

Omics lab services, which encompass genomics, transcriptomics, proteomics, and metabolomics, play a crucial role in the development of personalized medicine. As personalized medicine becomes more widespread, demand for omics lab services is increasing. Omics lab services are used extensively in drug discovery and development, helping researchers to better understand disease mechanisms and identify potential drug targets. As the demand for new and more effective drugs continues to rise, so does the demand for omics lab services. Advances in technology and analytical tools are enabling omics lab service providers to deliver more accurate and comprehensive data, and to do so more quickly and efficiently. This is making omics lab services more accessible and cost-effective and is driving the growth of the market. The prevalence of chronic diseases is increasing worldwide. Omics lab services are playing an increasingly important role in diagnosing, treating, and managing these diseases, thereby driving demand for these services. Investment in research and development is increasing globally as governments and private companies seek to drive innovation and improve healthcare outcomes. This investment is fueling the growth of the omics lab services market, as more resources are being directed towards research that relies on these services.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of omics lab services. The growth and trends of omics lab services industry provide a holistic approach to this study.

Market Segmentation:

This section of the omics lab services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Services

Genomics
Proteomics
Transcriptomic
Metabolomics
Epigenetics

By End-Use

Hardware Equipment (Instrument, Kits, Chips)
Testing / Lab (Services)
Analytics / Interpretation (Personalization And Interpretation)

By Product

One-Off
Repeat
Continuous

By Frequency Of Service

Hospitals
Research Institutes
Diagnostic Labs

By Business

Cancer
Pharmaco (Prescription, Non-Prescription)
Reproductive
Other Genetic Tests
Forensics
Population Studies
Skincare
Nutrition
Vitamins And Supplements
Genealogy
Other Categories

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Omics Lab Services market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the omics lab services market include Agilent Technologies Inc., Beijing Genomics Institute (BGI), Q2 Solutions, Spectrus, Flomics Biotech, PhenoSwitch Bioscience, QIAGEN, Quest Diagnostics Incorporated, Thermo Fisher Scientific, Inc., Illumina, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

Product Code: VMR112110524

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . OMICS LAB SERVICES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Services
- 3.7.2 Market Attractiveness Analysis By End-Use
- 3.7.3 Market Attractiveness Analysis By Product
- 3.7.4 Market Attractiveness Analysis By Frequency Of Service
- 3.7.5 Market Attractiveness Analysis By Business
- 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL OMICS LAB SERVICES MARKET ANALYSIS BY SERVICES

6.1 Overview by Services
6.2 Historical and Forecast Data
6.3 Analysis by Services
6.4 Genomics Historic and Forecast Sales by Regions
6.5 Proteomics Historic and Forecast Sales by Regions
6.6 Transcriptomic Historic and Forecast Sales by Regions
6.7 Metabolomics Historic and Forecast Sales by Regions
6.8 Epigenetics Historic and Forecast Sales by Regions

7 . GLOBAL OMICS LAB SERVICES MARKET ANALYSIS BY END-USE

7.1 Overview by End-Use
7.2 Historical and Forecast Data
7.3 Analysis by End-Use
7.4 Hardware Equipment (Instrument, Kits, Chips) Historic and Forecast Sales by Regions
7.5 Testing / Lab (Services) Historic and Forecast Sales by Regions
7.6 Analytics / Interpretation (Personalization And Interpretation) Historic and Forecast Sales by Regions

8 . GLOBAL OMICS LAB SERVICES MARKET ANALYSIS BY PRODUCT

8.1 Overview by Product
8.2 Historical and Forecast Data
8.3 Analysis by Product
8.4 One-off Historic and Forecast Sales by Regions
8.5 Repeat Historic and Forecast Sales by Regions
8.6 Continuous Historic and Forecast Sales by Regions

9 . GLOBAL OMICS LAB SERVICES MARKET ANALYSIS BY FREQUENCY OF SERVICE

9.1 Overview by Frequency Of Service
9.2 Historical and Forecast Data
9.3 Analysis by Frequency Of Service
9.4 Hospitals Historic and Forecast Sales by Regions
9.5 Research Institutes Historic and Forecast Sales by Regions
9.6 Diagnostic Labs Historic and Forecast Sales by Regions

10 . GLOBAL OMICS LAB SERVICES MARKET ANALYSIS BY BUSINESS

10.1 Overview by Business
10.2 Historical and Forecast Data
10.3 Analysis by Business
10.4 Cancer Historic and Forecast Sales by Regions
10.5 Pharmaco (Prescription, Non-Prescription) Historic and Forecast Sales by Regions
10.6 Reproductive Historic and Forecast Sales by Regions
10.7 Other Genetic Tests Historic and Forecast Sales by Regions
10.8 Forensics Historic and Forecast Sales by Regions
10.9 Population Studies Historic and Forecast Sales by Regions
10.10. Skincare Historic and Forecast Sales by Regions
10.11 Nutrition Historic and Forecast Sales by Regions
10.12 Vitamins And Supplements Historic and Forecast Sales by Regions
10.13 Genealogy Historic and Forecast Sales by Regions
10.14 Other Categories Historic and Forecast Sales by Regions

11 . GLOBAL OMICS LAB SERVICES MARKET ANALYSIS BY GEOGRAPHY

11.1. Top Company Share Analysis
11.2. Introduction
11.3. North America Sales Analysis
- 11.3.1. Overview, Historic and Forecast Sales Analysis
- 11.3.2. North America By Segment Sales Analysis
- 11.3.3. North America By Country Sales Analysis
- 11.3.4. United State Sales Analysis
- 11.3.5. Canada Sales Analysis
- 11.3.6. Mexico Sales Analysis
11.4. Europe Sales Analysis
- 11.4.1. Overview, Historic and Forecast Sales Analysis
- 11.4.2. Europe by Segment Sales Analysis
- 11.4.3. Europe by Country Sales Analysis
- 11.4.4. United Kingdom Sales Analysis
- 11.4.5. France Sales Analysis
- 11.4.6. Germany Sales Analysis
- 11.4.7. Italy Sales Analysis
- 11.4.8. Russia Sales Analysis
- 11.4.9. Rest Of Europe Sales Analysis
11.5. Asia Pacific Sales Analysis
- 11.5.1. Overview, Historic and Forecast Sales Analysis
- 11.5.2. Asia Pacific by Segment Sales Analysis
- 11.5.3. Asia Pacific by Country Sales Analysis
- 11.5.4. China Sales Analysis
- 11.5.5. India Sales Analysis
- 11.5.6. Japan Sales Analysis
- 11.5.7. South Korea Sales Analysis
- 11.5.8. Australia Sales Analysis
- 11.5.9. Rest Of Asia Pacific Sales Analysis
11.6. Latin America Sales Analysis
- 11.6.1. Overview, Historic and Forecast Sales Analysis
- 11.6.2. Latin America by Segment Sales Analysis
- 11.6.3. Latin America by Country Sales Analysis
- 11.6.4. Brazil Sales Analysis
- 11.6.5. Argentina Sales Analysis
- 11.6.6. Peru Sales Analysis
- 11.6.7. Chile Sales Analysis
- 11.6.8. Rest of Latin America Sales Analysis
11.7. Middle East & Africa Sales Analysis
- 11.7.1. Overview, Historic and Forecast Sales Analysis
- 11.7.2. Middle East & Africa by Segment Sales Analysis
- 11.7.3. Middle East & Africa by Country Sales Analysis
- 11.7.4. Saudi Arabia Sales Analysis
- 11.7.5. UAE Sales Analysis
- 11.7.6. Israel Sales Analysis
- 11.7.7. South Africa Sales Analysis
- 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE OMICS LAB SERVICES COMPANIES

12.1. Omics Lab Services Market Competition
12.2. Partnership/Collaboration/Agreement
12.3. Merger And Acquisitions
12.4. New Product Launch
12.5. Other Developments

13 . COMPANY PROFILES OF OMICS LAB SERVICES INDUSTRY

13.1. Company Share Analysis
13.2. Market Concentration Rate
13.3. Agilent Technologies Inc.
- 13.3.1. Company Overview
- 13.3.2. Company Revenue
- 13.3.3. Products
- 13.3.4. Recent Developments
13.4. Beijing Genomics Institute (BGI)
- 13.4.1. Company Overview
- 13.4.2. Company Revenue
- 13.4.3. Products
- 13.4.4. Recent Developments
13.5. Q2 Solutions
- 13.5.1. Company Overview
- 13.5.2. Company Revenue
- 13.5.3. Products
- 13.5.4. Recent Developments
13.6. Spectrus
- 13.6.1. Company Overview
- 13.6.2. Company Revenue
- 13.6.3. Products
- 13.6.4. Recent Developments
13.7. Flomics Biotech
- 13.7.1. Company Overview
- 13.7.2. Company Revenue
- 13.7.3. Products
- 13.7.4. Recent Developments
13.8. PhenoSwitch Bioscience
- 13.8.1. Company Overview
- 13.8.2. Company Revenue
- 13.8.3. Products
- 13.8.4. Recent Developments
13.9. QIAGEN
- 13.9.1. Company Overview
- 13.9.2. Company Revenue
- 13.9.3. Products
- 13.9.4. Recent Developments
13.10. Quest Diagnostics Incorporated
- 13.10.1. Company Overview
- 13.10.2. Company Revenue
- 13.10.3. Products
- 13.10.4. Recent Developments
13.11. Thermo Fisher Scientific Inc.
- 13.11.1. Company Overview
- 13.11.2. Company Revenue
- 13.11.3. Products
- 13.11.4. Recent Developments
13.12. Illumina Inc.
- 13.12.1. Company Overview
- 13.12.2. Company Revenue
- 13.12.3. Products
- 13.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies